Design
Review
Authors
Loading...
Current agents should not guide therapy by BP variability reduction; leaves open prospective validation of its prognostic value.
Key points are not available for this paper at this time.
Parati et al. (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: